Massive pulmonary embolism in rheumatoid patient treated with raloxifene : a case report

Abstract EN

-Introduction Rheumatoid arthritis (RA) is not generally considered a risk factor for venous thromboembolism.

Case presentation A patient with RA and postmenopausal osteoporosis was reported with massive pulmonary embolism following treatment with raloxifene for 3 months.

This patient met the American College of Rheumatology ( ACR) criteria for RA diagnosis in 1988.

She was controlled on regular disease modifying antirheumatic drug (DMARDs) for 4 years.

Conclusion Pulmonary embolism in postmenopausal osteoporotic patient with RA could be due to raloxifene treatment rather than a complication of the disease itself.